Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice
CX3C Motif Chemokine Ligand 1 (CX3CL1; fractalkine) has been implicated in the pathogenesis of rheumatoid arthritis (RA) and its inhibition was found to attenuate arthritis in mice as well as in a clinical trial. Therefore, we investigated the effects of an anti-CX3CL1 monoclonal antibody (mAb) on i...
Saved in:
Main Authors: | Satoshi Mizutani (Author), Junko Nishio (Author), Kanoh Kondo (Author), Kaori Motomura (Author), Zento Yamada (Author), Shotaro Masuoka (Author), Soichi Yamada (Author), Sei Muraoka (Author), Naoto Ishii (Author), Yoshikazu Kuboi (Author), Sho Sendo (Author), Tetuo Mikami (Author), Toshio Imai (Author), Toshihiro Nanki (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dental Health Physical Exercise (SKG) for Elderly
by: Fridaniyanti Khusnul Khotimah, et al.
Published: (2020) -
Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
by: Piotr Wojdasiewicz, et al.
Published: (2019) -
Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
by: Dariusz Szukiewicz, et al.
Published: (2013) -
Tenophages: a novel macrophage-like tendon cell population expressing CX3CL1 and CX3CR1
by: Christine Lehner, et al.
Published: (2019) -
CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice
by: Matthew Riopel, et al.
Published: (2019)